EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b

Andrea Aebischer iD, Anne Günther, Ronja Piesche, Kerstin Wernike iD, Magdalena Murr, Timm Harder iD, Donata Hoffmann, Christian Grund, Beatriz Bellido Martín, Ron Fouchier iD, Katharina Daniel, Leon Ullrich und 10 weitere

Journal of Clinical Microbiology · 2026

DOI: 10.1128/jcm.01907-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von Andrea Aebischer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Germany. Hauptthemen laut MEDLINE: Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus, Orthomyxoviridae Infections, Antigens, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Deutsche Forschungsgemeinschaft, European Vaccines Hub for Pandemic Readiness EU4H project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The highly pathogenic avian influenza viruses of subtype H5N1 represent a major threat to animal and public health. The current panzootic with H5 clade 2.3.4.4b has caused numerous, widespread outbreaks in various domestic and wild avian species with high mortalities, massive losses, and a high frequency of spillover events to unexpected novel mammalian hosts, such as dairy cows. The global H5N1 situation raises serious concerns about zoonotic risks due to effective mammal-to-mammal transmission. Therefore, it is critical to increase surveillance intensity of a broadened species range, particularly at the human-animal interface. For this purpose, reliable and cost-effective serological tools that are easy to perform and suitable for high-throughput screening are critically needed. The newly developed double-antigen enzyme-linked immunosorbent assay format employing a luminescence-based detection technology has demonstrated compliance with such prerequisites. The assay allowed sensitive and specific detection of antibodies directed against H5 hemagglutinin of clade 2.3.4.4b in a wide range of birds and mammals, including humans. Furthermore, it allowed differentiating H5 anti-head-specific from cross-reacting anti-stalk antibodies, which represents a valuable feature with regard to the monitoring of future vaccination programs with H5-specific vaccines. Thus, the assay is a significant contribution to existing serological diagnostic tests for a clade-optimized and species-independent detection of influenza A virus antibodies. IMPORTANCE The ongoing highly pathogenic avian influenza virus H5N1 panzootic has caused numerous outbreaks in domestic and wild animals, with frequent spillover events to unexpected host species, which underscores the importance of intensified surveillance. However, sensitive and specific multi-species serological assays represent a major gap. For this purpose, we developed a novel double-antigen enzyme-linked immunosorbent assay that employs an innovative luminescence-based readout strategy. The test allowed a highly sensitive and specific detection of H5-specific antibodies in a wide range of avian and mammalian species, including humans. It therefore represents a valuable contribution to improving species-independent serological diagnostic tools for the detection of influenza A virus antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralHemagglutinin Glycoproteins, Influenza VirusOrthomyxoviridae InfectionsAntigens, ViralInfluenza, HumanInfluenza A virusAnimalsEnzyme-Linked Immunosorbent AssayHumansSensitivity and SpecificityBirdsLuciferasesInfluenza in BirdsInfluenza A Virus, H5N1 SubtypeMammals

Stichwörter der Autor:innen

ELISAH5 clade 2.3.4.4bH5N1HPAIVantibodiesbirdshighly pathogenic avian influenza virusmammalsnanoluciferasepanzooticserologysurveillancewildlife

Substanzen

Antibodies, ViralHemagglutinin Glycoproteins, Influenza VirusLuciferasesAntigens, Viralhemagglutinin, avian influenza A virus

Autor:innen und Institutionen

  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Germany.
  • Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Germany.
  • Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, Institute of Translational Research, University of Cologne, Cologne, Germany.
  • German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.

ORCID-Profile: Andrea Aebischer, Kerstin Wernike, Timm Harder, Ron Fouchier, Rosanne Sprute, Florian Klein, Maryna Kuryshko, Martin Beer

Förderung

  • Horizon 2020
  • Deutsche Forschungsgemeinschaft
  • European Vaccines Hub for Pandemic Readiness EU4H project

Zitieren

APA

Aebischer, A., Günther, A., Piesche, R., Wernike, K., Murr, M., Harder, T., Hoffmann, D., Grund, C., Bellido Martín, B., Fouchier, R., Daniel, K., Ullrich, L., Sprute, R., Kreer, C., Klein, F., Roller, M., Reese, L., Wassermann, J., Schares, G., …, & Beer, M. (2026). Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01907-25

Vancouver

Aebischer A, Günther A, Piesche R, Wernike K, Murr M, Harder T, et al. Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.01907-25

BibTeX
@article{Aebischer2026,
  author = {Aebischer, Andrea and Günther, Anne and Piesche, Ronja and Wernike, Kerstin and Murr, Magdalena and Harder, Timm and Hoffmann, Donata and Grund, Christian and Bellido Martín, Beatriz and Fouchier, Ron and Daniel, Katharina and Ullrich, Leon and Sprute, Rosanne and Kreer, Christoph and Klein, Florian and Roller, Marco and Reese, Lukas and Wassermann, Josefine and Schares, Gereon and Kuryshko, Maryna and Abdelwhab, Elsayed M and Beer, Martin},
  title = {Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  doi = {10.1128/jcm.01907-25}
}
Kostenlos starten →